| Name | Title | Contact Details |
|---|
Skagit Regional Health includes Skagit Valley Hospital, Skagit Regional Clinics and Cascade Valley Hospital. Skagit Regional Health is a health care leader in Northwest Washington, providing advanced, quality and comprehensive services to the people of our communities. Skagit Valley Hospital is home to the area`s only cardiac catheterization labs and offers advanced heart and vascular care. Skagit Valley Hospital leads the way in comprehensive cancer care and is a network member of the Seattle Cancer Care Alliance, which brings together the talents and research power of Fred Hutchinson Cancer Research Center, UW Medicine and Seattle Children`s. Skagit Valley Hospital is licensed for 137 beds, features a full range of services including comprehensive cancer care; surgical services; a Level III Emergency Department; a well-appointed Family Birth Center; comprehensive diagnostics; and advanced heart and vascular care. Skagit Regional Clinics is a network of 19 health care facilities providing primary and specialty outpatient care in north Snohomish, Island and Skagit counties. Cascade Valley Hospital is a 48-bed acute care facility in Arlington, with a free-standing surgery center and wound care center. Cascade Valley Hospital provides acute, critical care, general surgery, a level IV Emergency Department, and Family Birthing Center, plus a wide array of outpatient and diagnostic imaging services. Skagit Regional Health is Skagit County`s largest employer and the third largest public district hospital in the State of Washington.
Wisteria Cottage is a Sequim, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Western Kentucky Regional Blood Center is a Owensboro, KY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
PharmaBlock Sciences (Nanjing), Inc. is a leading innovative chemistry products and services provider throughout the pharmaceutical R&D process. Its core businesses include: a catalog of specially designed scaffolds and building blocks; custom synthesis; process development; manufacturing of key intermediates and RSMs; and FTE services. The company was listed on Shenzhen Exchange Stock in China on November 10, 2017. PharmaBlock has rapidly gained recognition for its outstanding capability in the design, synthesis, and supply of lab scale building blocks. Building on that success, the company acquired Shandong Diai Biotechnology Co., Ltd. as its pilot plant and manufacturing site in 2016, and is providing scale-up synthesis and manufacturing of key intermediates/RSMs. PharmaBlock is now committed to a more comprehensive and long-term service to valued customers.
HPS Group is a Silver Spring, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.